| Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study MAP Dominik Menges, Tala Ballouz, Alexia Anagnostopoulos, Hélène E. Aschmann ... PlosOne 16 (7), e0254523, 2021 | 295* | 2021 |
| Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and … HG Yebyo, HE Aschmann, M Kaufmann, MA Puhan American heart journal 210, 18-28, 2019 | 167 | 2019 |
| Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study T Ballouz, D Menges, A Anagnostopoulos, A Domenghino, HE Aschmann, ... bmj 381, 2023 | 67 | 2023 |
| Finding the balance between benefits and harms when using statins for primary prevention of cardiovascular disease: a modeling study HG Yebyo, HE Aschmann, MA Puhan Annals of internal medicine 170 (1), 1-10, 2019 | 67 | 2019 |
| Finding the balance between benefits and harms when using statins for primary prevention of cardiovascular disease: a modeling study HG Yebyo, HE Aschmann, MA Puhan Annals of internal medicine 170 (1), 1-10, 2019 | 67 | 2019 |
| When barriers ignore the “rule-of-five” SD Krämer, HE Aschmann, M Hatibovic, KF Hermann, CS Neuhaus, ... Advanced drug delivery reviews 101, 62-74, 2016 | 64 | 2016 |
| A physiologically based pharmacokinetic model of isoniazid and its application in individualizing tuberculosis chemotherapy H Cordes, C Thiel, HE Aschmann, V Baier, LM Blank, L Kuepfer Antimicrobial agents and chemotherapy 60 (10), 6134-6145, 2016 | 53 | 2016 |
| Assessment of patient-preferred language to achieve goal-aligned deprescribing in older adults AR Green, H Aschmann, CM Boyd, N Schoenborn JAMA Network Open 4 (4), e212633-e212633, 2021 | 33 | 2021 |
| Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub … HG Yebyo, HE Aschmann, T Yu, MA Puhan BMC cardiovascular disorders 18, 1-11, 2018 | 30 | 2018 |
| A data-driven simulation of the exposure notification cascade for digital contact tracing of SARS-CoV-2 in Zurich, Switzerland D Menges, HE Aschmann, A Moser, CL Althaus, V von Wyl JAMA network open 4 (4), e218184-e218184, 2021 | 27 | 2021 |
| COVID-19 mortality and excess mortality among working-age residents in California, USA, by occupational sector: a longitudinal cohort analysis of mortality surveillance data YH Chen, AR Riley, KA Duchowny, HE Aschmann, R Chen, MV Kiang, ... The Lancet Public Health 7 (9), e744-e753, 2022 | 26 | 2022 |
| A benefit–harm analysis of adding basal insulin vs. sulfonylurea to metformin to manage type II diabetes mellitus in people with multiple chronic conditions WL Bennett, HE Aschmann, MA Puhan, CW Robbins, EA Bayliss, ... Journal of clinical epidemiology 113, 92-100, 2019 | 22 | 2019 |
| Kinetics of lipid bilayer permeation of a series of ionisable drugs and their correlation with human transporter-independent intestinal permeability KF Hermann, CS Neuhaus, V Micallef, B Wagner, M Hatibovic, ... European Journal of Pharmaceutical Sciences 104, 150-161, 2017 | 22 | 2017 |
| Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort D Menges, KD Zens, T Ballouz, N Caduff, D Llanas-Cornejo, ... Nature Communications 13 (1), 4855, 2022 | 21 | 2022 |
| The role of the SwissCovid digital proximity tracing app during the pandemic response: results for the Canton of Zurich D Menges, H Aschmann, A Moser, CL Althaus, V von Wyl medRxiv, 2021.02. 01.21250972, 2021 | 19 | 2021 |
| Informing Patient-Centered Care Through Stakeholder Engagement and Highly Stratified Quantitative Benefit–Harm Assessments HE Aschmann, CM Boyd, CW Robbins, WV Chan, RA Mularski, ... Value in Health 23 (5), 616-624, 2020 | 19 | 2020 |
| Racial and ethnic disparities in estimated excess mortality from external causes in the US, March to December 2020 R Chen, HE Aschmann, YH Chen, MM Glymour, K Bibbins-Domingo, ... JAMA Internal Medicine 182 (7), 776-778, 2022 | 18 | 2022 |
| A comparative analysis of drug-induced hepatotoxicity in clinically relevant situations C Thiel, H Cordes, L Fabbri, HE Aschmann, V Baier, I Smit, F Atkinson, ... PLoS computational biology 13 (2), e1005280, 2017 | 18 | 2017 |
| Dynamics of racial disparities in all-cause mortality during the COVID-19 pandemic HE Aschmann, AR Riley, R Chen, YH Chen, K Bibbins-Domingo, ... Proceedings of the National Academy of Sciences 119 (40), e2210941119, 2022 | 16 | 2022 |
| Adherence and association of digital proximity tracing app notifications with earlier time to quarantine: results from the Zurich SARS-CoV-2 cohort study T Ballouz, D Menges, HE Aschmann, A Domenghino, JS Fehr, MA Puhan, ... International Journal of Public Health 66, 1603992, 2021 | 15 | 2021 |
